Vanguard Capital Management’s HCW Biologics HCWB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.43K Buy
2,005
+2
+0.1% +$6 ﹤0.01% 4050
2026
Q2
$10K Sell
2,003
-1
-0% -$6 ﹤0.01% 4051
2026
Q1
$4.33K Buy
+2,004
New +$10.4K ﹤0.01% 4040

Other funds holding HCWB

Vanguard Capital Management's HCWB Position: Q3 2026 in Review

Vanguard Capital Management increased its HCW Biologics (HCWB) stake by 0.1% in Q3 2026, buying an estimated $6 and bringing the position to 2,005 shares worth $3.43K. The position accounts for ﹤0.01% of the portfolio, ranked #4050.

Vanguard Capital Management first reported a position in HCWB in Q1 2026 and has held it in 3 quarters since. The position peaked at $10K in Q2 2026. 12 funds tracked by Wall St. Rank hold HCWB as of Q3 2026.

  • Vanguard Capital Management held 2,005 shares of HCW Biologics worth $3.43K as of Q3 2026.
  • Vanguard Capital Management bought 2 HCW Biologics shares in Q3 2026, an estimated $6.
  • HCW Biologics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #4050 holding.
  • Vanguard Capital Management first reported a position in HCW Biologics in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's HCW Biologics position peaked at $10K in Q2 2026.
  • 12 funds tracked by Wall St. Rank held HCW Biologics as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.